Patent · US Active

Monoclonal antibodies specific to hemagglutinin and neuraminidase from influenza virus H5-subtype or N1-subtype and uses thereof

US8574581B2 · kind B2 · utility

12Cited by
0References
24Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 11, 2012
Grant dateNov 5, 2013
Priority date
Expiry dateSep 11, 2032

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2333/11
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Monoclonal antibodies and related binding proteins that bind specifically to the envelope glycoprotein of H5 subtypes or neuraminidase glycoprotein of N1 subtypes of avian influenza virus (AIV) are provided. The monoclonal antibodies and related binding proteins are useful for the detection of H5 and N1 subtypes of AIV, including H5N1 subtypes and provide means for the diagnosis, surveillance and treatment of dangerous viral infections.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.